ABSTRACT
A. Inhaled high-dose steroids B. Inhaled low-dose steroids C. Inhaled short-acting β2-agonist D. Intravenous magnesium sulphate E. Nebulized short-acting β2-agonist F. No further management required G. No treatment required H. Oral leukotriene receptor antagonist I. Oral steroids J. Oxygen via facemask and inhaled short-acting β2-agonist K. Oxygen via facemask, inhaled short-acting β2-agonist and steroids L. Oxygen via facemask and nebulized short-acting β2-agonist M. Oxygen via facemask, nebulized short-acting β2-agonist and steroids
For each of the following scenarios, select the most appropriate management. Each option may be used once, more than once or not at all.
